Problem

Biocomm GPT™ is an artificial intelligence large language model (“LLM”) based on generative pre-trained transformer (“GPT”) technology.

Solution

NormaxAI proposes a Virtual Tumor Board (VTB) that leverages AI and advanced technologies to overcome these limitations.

Key Features of VTB

Accesibility

Virtual participation eliminates geographical constraints and allows for wider expert involvement.

Effieciency

Reduces travel time and costs for both doctors and patients, leading to faster diagnosis and treatment planning.

Collaboration

Facilitates seamless interaction and knowledge sharing between diverse specialists, including oncologists,surgeons, radiologists, and pathologists.

AI-powered Insights

Utilizes AI tools like MedicalGPT and Gemini API to analyze multimodal patient data (e.g., images, EMR,genomics) and provide insightful recommendations to support clinical decision-making.

Personalized Medicine

Integrates with Normax’s EARTh GMP process to develop and deliver personalized mRNAimmunotherapies based on individual tumor profiles.

Data Security & Compliance

Ensures patient data privacy by adhering to HIPAA and GDPR regulations.

Technology & Tools

  • Apple Vision Pro: Provides an immersive user interface for doctors and patients.
  • MedicalGPT: LLM for medical knowledge sharing and learning.
  • Biocomm.Net: Patient community app for information and support.
  • SafeAI Data Center: Prototype AI JV with MTIF-NTU for secure data storage and processing.

Benefits:

Improved patient care and outcomes.

Enhanced collaboration and learning opportunities.

Development of personalized medicine protocols.

Reduced healthcare costs and increased efficiency.

Collaboration & Partnerships

  • MTIF-NTU: Joint venture for innovation and discovery in personalized medicine and AI.
  • Google Cloud & DeepMind: Leveraging Google’s AI expertise and cloud infrastructure.
  • Thermo Fisher: Potential collaboration for mRNA therapeutics development and manufacturing.

Next Steps

  • Secure funding and establish partnerships.
  • Develop and deploy VTB at MTIF-NTU and other hospitals.
  • Integrate VTB with EARTh GMP process for personalized medicine delivery.
  • Conduct clinical trials and research to demonstrate VTB’s effectiveness.

Join un in the future of AI empowered healthcare.

Contact

info@nrvx.net